Coalition set up to find solutions to the challenge of safe, sustainable and adequate blood in Africa
Today, a collaboration of stakeholders in the public and private sectors across sub-Saharan Africa (SSA) launched the Coalition of Blood for Africa (CoBA) on a virtual platform. This reflects a growing consensus that progress toward adequate, safe and sustainable blood in Africa requires multi-stakeholder, multi-pronged and innovative approaches to impact lives across the continent.
Blood is a vital healthcare resource. It is most often used in Africa to treat pregnancy-related complications and severe childhood anemia that is caused by a variety of contributors including malaria and sickle cell disease. Blood is increasingly important for patients with kidneyfailure who are on dialysis and to help cancer patients.
“Today is about mobilizing action, as we convene the first ever Coalition of Blood in Africa,” said Antoinette Gawin, President and Chief Executive Officer, Terumo Blood and Cell Technologies. “The coalition’s goal is to support the World Health Organization’s commitments[WHA63.12] and aligns with our global mission to serve more patients. Providing safe access to blood in Africa is one way to achieve this.”
The coalition is anchored on three pillars:
The coalition brings together an unprecedented array of health experts, including public-sector research institutes, ministries of health, academia, not-for-profit research and development organizations, NGOs, international organizations and funders all committed to finding solutions to address the challenges facing access to safe, sustainable blood in Africa.
“The scale of the challenge is clearly beyond the scope of a single organization and I am confident that the Coalition will facilitate a coordinated approach to address the challenges facing blood in Africa and find sustainable solutions,” says Gavin Evans, Executive Director, Global Blood Fund.
The launch of CoBA was convened by Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis and cell technology,in collaboration with Global Blood Fund, Africa Practice, Africa Health Business and Siemens Healthineers.